Coagulation Factor IX, Human, recombinant
ATC (Anatomical Therapeutic Chemical Classification)
Blood coagulation factor substitute
- Factor IX coagulationis humanus (ADNr) (Latin)
- Blutgerinnungsfaktor IX vom Menschen, rekombinant (German)
- Facteur de coagulation humain, recombinant (French)
Baxter, Spain; Baxter, Ireland; Biovitrum, Sweden; Pfizer, Switzerland; Wyeth, Austria; Wyeth, Australia; Wyeth, Belgium; Wyeth, Brazil; Wyeth, Canada; Wyeth, Chile; Wyeth, Colombia; Wyeth, Czech Republic; Wyeth, Germany; Wyeth, Denmark; Wyeth, Finland; Wyeth, France; Wyeth, Greece; Wyeth, Hungary; Wyeth, Iceland; Wyeth, Italy; Wyeth, Luxembourg; Wyeth, Netherlands; Wyeth, New Zealand; Wyeth, Sweden; Wyeth, Taiwan; Wyeth, United States; Wyeth, Venezuela; Wyeth Europa, Norway; Wyeth Pharmaceuticals, United Kingdom
Swedish Orphan, Germany
|BAN||British Approved Name|
|JAN||Japanese Accepted Name|
|USAN||United States Adopted Name|
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.